Columbia University Medical Center
New York, 10032, United States
NCT Number: NCT03797469
This study seeks to test whether these over-the-counter nutritional supplements have an impact on patients' performance during visual field testing.
Looking for future studies?
Notify Me40 year–80 year
All sexes
Interventional
Not applicable
New York, 10032, United States
Glaucoma is the leading cause of irreversible blindness worldwide. The most important test to detect progression is visual field testing. Visual field testing is the reference standard to measure visual function in glaucoma. It is called called standard automated perimetry (SAP). However, this test is very subjective, often unreliable, and variable. One of the main causes of unreliable tests is the lack of attentiveness or concentration during the test. Previous studies have shown that listening to Mozart or taking vitamin B12 can improve the reliability of this test. Recent studies have suggested that over-the-counter medications such as nicotinamide (vitamin B3) and pyruvate can also improve the performance during this test. This can ultimately reduce costs due to repeated testing and increase doctor's certainty when analyzing the results of this test.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3 tablets of 1000 mg each will be administered orally.
Other names: B-3 Nicotinamide
2 tablets of 1500 mg each will be administered orally.
Other names: Calcium Pyruvate
Tablets will look identical to the supplements and the number of tablets will equal the amount of supplements provided.
Time frame: Up to 20 weeks
Changes in 24-2 visual field results based upon point-wise and global metrics before and after intervention, and between treatment and placebo groups will be compared.
Time frame: Up to 20 weeks
Montreal Cognitive Assessment (MoCA) score before and after intervention and correlate these changes with those seen on visual field tests will be compared. The Montreal Cognitive Assessment (MoCA) is a brief 30-question test that assesses different types of cognitive abilities. Scores on the MoCA range from zero to 30, with a score of 26 and higher generally considered normal.
Columbia University
Other
Nutritional Supplements and Performance During Visual Field Testing
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05150197
Eye Diseases, Glaucoma
Durham, North Carolina, United States
View Trial DetailsNCT04175444
Visual Field Defect, Peripheral
Nashville, Tennessee, United States
View Trial DetailsNCT05169983
Visual Field Defect, Peripheral
Southampton, United Kingdom
View Trial DetailsNCT04786886
Visual Field Defect, Nasal Step, Visual Field Defect, Paracentral Scotoma of Both Eyes
Miami, Florida, United States
View Trial Details